Literature DB >> 22095662

The astrocytic lineage marker calmodulin-regulated spectrin-associated protein 1 (Camsap1): phenotypic heterogeneity of newly born Camsap1-expressing cells in injured mouse brain.

Nozomu Yoshioka1, Hiroaki Asou, Shin-Ichi Hisanaga, Hitoshi Kawano.   

Abstract

Calmodulin-regulated spectrin-associated protein 1 (Camsap1) has been recognized as a new marker for astrocytic lineage cells and is expressed on mature astrocytes in the adult brain (Yamamoto et al. [2009] J. Neurosci. Res. 87:503–513). In the present study, we found that newly born Camsap1-expressing cells exhibited regional heterogeneity in an early phase after stab injury of the mouse brain. In the surrounding area of the lesion site, Camsap1 was expressed on quiescent astrocytes. At 3 days after injury, Camsap1 immunoreactivity was upregulated on glial fibrillary acidic protein-immunoreactive (GFAP-ir) astrocytes. Some of these astrocytes incorporated bromodeoxyuridine (BrdU) together with re-expression of the embryonic cytoskeleton protein nestin. In the neighboring region of the lesion cavity, Camsap1 was expressed on GFAP-negative cells. At 3 days after injury, GFAP-ir astrocytes were absent around the lesion cavity. At this stage, NG2-ir cells immunopositive for Camsap1 and immunonegative for GFAP were distributed in border of the lesion cavity. By 10 days, Camsap1 immunoreactivity was exclusively detected on GFAP-ir reactive astrocytes devoid of NG2 immunoreactivity. BrdU pulse-chase labeling assay suggested the differentiation of Camsap1+/NG2+ cells into Camsap1+/GFAP+ astrocytes. In the subependymal zone of the lateral ventricle, Camsap1-ir cells increased after injury. Camsap1 immunoreactivity was distributed on ependymal and subependymal cells bearing various astrocyte markers, and BrdU incorporation was enhanced on such Camsap1-ir cells after injury. These results suggest that newly born reactive astrocytes are derived from heterogeneous Camsap1-expressing cells in the injured brain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22095662     DOI: 10.1002/cne.22788

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension.

Authors:  Wencheng Li; Hua Peng; Theresa Cao; Ryosuke Sato; Sarah J McDaniels; Hiroyuki Kobori; L Gabriel Navar; Yumei Feng
Journal:  Hypertension       Date:  2012-04-23       Impact factor: 10.190

2.  Development of astrocyte morphology and function in mouse visual thalamus.

Authors:  Rachana D Somaiya; Natalie A Huebschman; Lata Chaunsali; Ubadah Sabbagh; Gabriela L Carrillo; Bhanu P Tewari; Michael A Fox
Journal:  J Comp Neurol       Date:  2021-10-25       Impact factor: 3.215

Review 3.  Role of the lesion scar in the response to damage and repair of the central nervous system.

Authors:  Hitoshi Kawano; Junko Kimura-Kuroda; Yukari Komuta; Nozomu Yoshioka; Hong Peng Li; Koki Kawamura; Ying Li; Geoffrey Raisman
Journal:  Cell Tissue Res       Date:  2012-02-25       Impact factor: 5.249

4.  circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression.

Authors:  Zizheng Chen; Wenbin Xu; Deguang Zhang; Junjie Chu; Shuying Shen; Yan Ma; Qingxin Wang; Gang Liu; Teng Yao; Yizhen Huang; Huali Ye; Jiying Wang; Jianjun Ma; Shunwu Fan
Journal:  Mol Ther Nucleic Acids       Date:  2020-12-23       Impact factor: 8.886

5.  Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells.

Authors:  Cristina Ottone; Benjamin Krusche; Ariadne Whitby; Melanie Clements; Giorgia Quadrato; Mara E Pitulescu; Ralf H Adams; Simona Parrinello
Journal:  Nat Cell Biol       Date:  2014-10-05       Impact factor: 28.824

6.  Abnormalities in perineuronal nets and behavior in mice lacking CSGalNAcT1, a key enzyme in chondroitin sulfate synthesis.

Authors:  Nozomu Yoshioka; Shinji Miyata; Atsushi Tamada; Yumi Watanabe; Asami Kawasaki; Hiroshi Kitagawa; Keizo Takao; Tsuyoshi Miyakawa; Kosei Takeuchi; Michihiro Igarashi
Journal:  Mol Brain       Date:  2017-10-05       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.